Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

Update Il y a 4 ans
Reference: NCT02279966

Woman and Man

Extract

To assess the efficacy of acute treatment with 10 mg/day vortioxetine versus placebo on cognitive performance (focusing on the aspect concerning speed of processing, executive functioning, attention) in working patients with major depressive disorder (MDD).


Inclusion criteria

  • Major Depressive Disorder


Links